Key result
The mRNA bivalent booster was evaluated for neutralization efficiency against wild-type virus and omicron subvariants BA.1, BA.5, BA.2.75.2, BQ.1.1, and XBB.
Why the study?
Does the mRNA Bivalent Booster improve neutralization efficiency against wild-type and omicron subvariants?
Does the mRNA Bivalent Booster improve neutralization efficiency against wild-type and omicron subvariants?
The study evaluates the neutralization efficiency of mRNA bivalent boosters against emerging SARS-CoV-2 omicron subvariants.
No takes yet. Share an insight, caveat, or question.
Bivalent boosters show retained neutralization against recent omicron subvariants; leaves open clinical protection and need for updated formulations.
Davis-Gardner et al. (2022) studied this question. The mRNA bivalent booster was evaluated for neutralization efficiency against wild-type virus and omicron subvariants BA.1, BA.5, BA.2.75.2, BQ.1.1, and XBB.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: